Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

JANXJANX
14 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in JANUX THERAPEUTICS INC

Qube Research & Technologies Ltd holds 702,057 shares of JANX (JANUX THERAPEUTICS INC), worth $10.8M as of 2026-Q2. The position was increased (+256.1% shares). JANX represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$10.8M

Current Shares

702,057

Total Value Change

+$10.4M

Total Shares Change

+687,748

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
702,057
+256.1%
$10.8M0.0%$15.36
45
2026-Q1
Decreased
197,145
-8.7%
$2.7M0.0%$13.44
0
2025-Q4
Increased
216,005
+94.9%
$3M0.0%$13.83
42
2025-Q3
Decreased
110,849
-55.3%
$2.7M0.0%$23.70
0
2025-Q2
Decreased
247,873
-18.3%
$5.7M0.0%$23.15
0
2025-Q1
Increased
303,194
+32.2%
$8.2M0.0%$29.10
35
2024-Q4
New
229,390
-
$12.3M0.0%$52.50
39
2024-Q3
Exited
0
-100.0%
$00.0%$46.25
0
2024-Q2
New
10,034
-
$420,3240.0%$41.89
33
2023-Q4
Exited
0
-100.0%
$00.0%$10.73
0
2023-Q3
Decreased
8,735
-30.9%
$88,0490.0%$10.08
0
2023-Q2
New
12,641
-
$150,0490.0%$11.53
31
2021-Q3
Exited
0
-100.0%
$00.0%$22.93
0
2021-Q2
New
14,309
-
$357,0000.0%$25.37
33

Other major holders of JANX: RA CAPITAL MANAGEMENT, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used